Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia and internationally. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. Medical Developments International Limited is headquartered in Scoresby, Australia.
Industry, Sector and Symbol
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone61 3 9547 1888
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.18 million
Profitability
Miscellaneous
Employees55
Next Earnings DateN/A
OptionableNot Optionable
Medical Developments International (ASX:MVP) Frequently Asked Questions
What is Medical Developments International's stock symbol?
Medical Developments International trades on the ASX under the ticker symbol "MVP."
How often does Medical Developments International pay dividends? What is the dividend yield for Medical Developments International?
Medical Developments International announced a Interim dividend on Friday, February 22nd. Investors of record on Wednesday, April 17th will be given a dividend of 0.02 per share on Wednesday, April 17th. This represents a yield of 0.53%. The ex-dividend date is Thursday, March 7th. View Medical Developments International's Dividend History.
Has Medical Developments International been receiving favorable news coverage?
News articles about MVP stock have trended positive on Friday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Medical Developments International earned a media sentiment score of 2.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term.
Who are some of Medical Developments International's key competitors?
Some companies that are related to Medical Developments International include Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY), Futura Medical (FUM), Vita Life Sciences (VLS), Cathay International (CTI), Patrys (PAB), Recce Pharmaceuticals (RCE), Avivagen (VIV) and Antisense Therapeutics (ANP).
Who are Medical Developments International's key executives?
Medical Developments International's management team includes the folowing people:
- Mr. John Stewart Sharman, Chief Exec. Officer (Age 53)
- Mr. Mark Edwards, CFO & Company Sec.
- Dr. Scott Courtney, Director of Research & Operations
- Michelle Bradney, Head of Medical Affairs
- Wai Ng Chi, Head of Regulatory Affairs
What is Medical Developments International's stock price today?
One share of MVP stock can currently be purchased for approximately A$5.30.
How big of a company is Medical Developments International?
Medical Developments International has a market capitalization of $347.24 million and generates $19.18 million in revenue each year. Medical Developments International employs 55 workers across the globe.
What is Medical Developments International's official website?
How can I contact Medical Developments International?
The company can be reached via phone at 61 3 9547 1888.
MarketBeat Community Rating for Medical Developments International (ASX MVP)
MarketBeat's community ratings are surveys of what our community members think about Medical Developments International and other stocks. Vote "Outperform" if you believe MVP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MVP will underperform the S&P 500 over the long term. You may vote once every thirty days.
